Patrick Soon-Shiong

1 week ago | urotoday.com | Patrick Soon-Shiong

Read the Full Video TranscriptAshish Kamat: A warm welcome to all of you from the UroToday studios. I'm Ashish Kamat, Professor of Urologic Oncology at MD Anderson Cancer Center in Houston, Texas. And we are live at AUA 2025, in Las Vegas. It's a great pleasure to welcome to the studios Dr. Patrick Soon‑Shiong, who really needs no introduction. Patrick, thank you so much for taking the time and welcome. Patrick Soon‑Shiong: Thank you for having me.

1 week ago | urotoday.com | Patrick Soon-Shiong

Read the Full Video TranscriptAshish Kamat: A warm welcome to all of you from the UroToday studios. I'm Ashish Kamat, Professor of Urologic Oncology at MD Anderson Cancer Center in Houston, Texas. And we are live at AUA 2025 in Las Vegas. It's a great pleasure to welcome to the studios Dr. Patrick Soon-Shiong, who really needs no introduction. Patrick, thank you so much for taking the time. And welcome. Patrick Soon-Shiong: Thank you. Thank you for having me.

Feb 6, 2025 | urologytimes.com | Patrick Soon-Shiong

In this interview, Patrick Soon-Shiong, MD, shares key updates in the development of nogapendekin alfa inbakicept-pmln (Anktiva), which was approved by the FDA in April 2024 for patients with BCG-unresponsive non–muscle invasive bladder cancer (NMIBC) with carcinoma in situ (CIS) with or without papillary tumors. Soon-Shiong is the executive chairman and global chief scientific and medical officer at ImmunityBio. What is the mechanism of action for Anktiva?

May 16, 2024 | urotoday.com | Patrick Soon-Shiong

Read the Full Video TranscriptAshish Kamat: So everyone, welcome to part two of this discussion that we're having with Dr. Patrick Soon-Shiong, who again has taken the time to come here to the UroToday Studio, share his knowledge, and his experience with our audience.

May 16, 2024 | urotoday.com | Patrick Soon-Shiong

Read the Full Video TranscriptAshish Kamat: So everyone, welcome to part two of this discussion that we're having with Dr. Patrick Soon-Shiong, who again has taken the time to come here to the UroToday Studio, share his knowledge, and his experience with our audience.